Form 4: ARTIVION CCO Davis Acquires, Sells Shares

ARTIVION's Chief Commercial Officer, John E. Davis, reported the acquisition of performance stock units and a subsequent sale of shares to cover tax obligations.

Summary

• John E. Davis, Chief Commercial Officer of ARTIVION, INC. (AORT), acquired 28,845 shares of common stock on March 2, 2026, at a price of $0.
• These shares represent the vesting of one-third of performance stock units granted on February 28, 2025.
• The remaining performance stock units from the February 2025 grant are scheduled to vest in two equal installments: one-third on February 28, 2027, and one-third on February 28, 2028, contingent on continued employment.
• On March 3, 2026, Mr. Davis sold 4,573 shares of common stock at a price of $37.7756 per share.
• This sale was a non-discretionary 'sell to cover' transaction, executed solely to satisfy tax withholding obligations arising from the vesting of the performance stock units.
• Following these transactions, Mr. Davis beneficially owns 230,794 shares of ARTIVION common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It reports routine executive compensation events (vesting and tax-related sale) that are generally pre-scheduled and do not reflect discretionary trading decisions or significant new information about the company's operational or financial performance.

Positives

• The vesting of 28,845 performance stock units indicates that performance targets associated with the February 2025 grant were met, reflecting positively on company and executive performance.
• The acquisition of shares at a $0 price represents a significant compensation event for the Chief Commercial Officer, aligning executive incentives with shareholder value.

Negatives

• The sale of 4,573 shares, even for tax purposes, results in a reduction of the Chief Commercial Officer's direct beneficial ownership in the company.

Future Outlook

The filing indicates future vesting events for the remaining performance stock units granted in February 2025, with one-third scheduled to vest on February 28, 2027, and the final one-third on February 28, 2028, subject to continued employment.

Industry Context

StockSavvy.ai notes that the vesting of performance stock units and subsequent 'sell to cover' transactions are routine events in executive compensation across various industries. These transactions are typically pre-planned under Rule 10b5-1(c) plans and are generally not indicative of an executive's discretionary view on the company's immediate stock performance, unlike open market purchases or sales.

Stakeholder Impact

• Shareholders: The transactions represent a routine compensation event for a key executive, with a minor reduction in direct insider ownership due to tax-related sales. The vesting itself indicates performance targets were met.
• Employees: The vesting schedule for performance stock units highlights the company's long-term incentive structure for executives, potentially influencing broader employee compensation strategies.

Next Steps

• Future vesting of remaining performance stock units on February 28, 2027, and February 28, 2028, contingent on John E. Davis's continued employment.

Key Dates

Recommendation

The filing details routine executive compensation events, specifically the vesting of performance stock units and a subsequent 'sell to cover' transaction for tax purposes. These are pre-planned and non-discretionary, offering no new material information that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate as the filing does not present new catalysts for significant price movement.

Keywords

ARTIVION, AORT, John E. Davis, Chief Commercial Officer, Form 4, Insider Trading, Performance Stock Units, Stock Vesting, Sell to Cover, Executive Compensation